Inovio Pharmaceuticals, Inc. (INO) Presents at Piper Sandler 37th Annual Healthcare Conference TranscriptSeeking Alpha • 12/02/25
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business HighlightsPRNewsWire • 11/10/25
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in AdultsPRNewsWire • 11/03/25
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat ConferencePRNewsWire • 10/23/25
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature MedicinePRNewsWire • 10/21/25
Inovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)Seeking Alpha • 09/05/25
INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease DrugZacks Investment Research • 08/28/25
INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in AdultsPRNewsWire • 08/26/25
INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment ConferencePRNewsWire • 08/25/25
INOVIO Reports Second Quarter 2025 Financial Results and Recent Business HighlightsPRNewsWire • 08/12/25
Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)PRNewsWire • 08/11/25
Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 08/05/25
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business DevelopmentGlobeNewsWire • 07/01/25
Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/13/25